Text Messaging to Reduce High-risk Alcohol Use Among Older Adults
NCT ID: NCT06319885
Last Updated: 2025-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-04-15
2025-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Messaging Interventions to Reduce Alcohol Problems Project
NCT03695653
Implementing Mobile Technology for Unhealthy Alcohol Use
NCT05350878
Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use
NCT06318975
Web-based Ultra-brief Intervention for Heavy Drinkers Trial
NCT00751985
Brief Intervention for Heavy Drinkers
NCT00728767
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gain-framed
One daily text-message and weekly alcohol use assessment. The text-messages focus on the positive consequences of drinking less.
Text messaging
Participants receive text messages related to their alcohol consumption.
Loss-framed
One daily text-message and weekly alcohol use assessment. The text-messages focus on the negative consequences of a high alcohol-intake.
Text messaging
Participants receive text messages related to their alcohol consumption.
Static-tailored
One daily text-message and weekly alcohol use assessment. The text-messages are adapted to the participant's gender and to baseline information on (e.g.) participants' drinking patterns, social network, and self-efficacy. One message per week is adapted to the day on which the participants find it most challenging to reduce their drinking.
Text messaging
Participants receive text messages related to their alcohol consumption.
Adaptive-tailored
One daily text-message and weekly alcohol use assessment. The text-messages are adapted to the participant's gender and to baseline information on (e.g.) participants' drinking patterns, social network, and self-efficacy. One message per week is adapted to the day on which the participants find it most challenging to reduce their drinking. In addition, text messages are adapted to the weekly alcohol-assessment over time and participants can demand supportive Just-In-Time messages.
Text messaging
Participants receive text messages related to their alcohol consumption.
Combined
This arm combines all features of the arms Adaptive-tailored and Gain-framed.
Text messaging
Participants receive text messages related to their alcohol consumption.
Assessment-only
The control group. Participants do only receive 4 questions on their alcohol intake once a week.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Text messaging
Participants receive text messages related to their alcohol consumption.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* desire to reduce drinking
* age 55 to 80 years
* mobile phone ownership and willingness to receive and respond to text messages
* fluency in Danish.
Exclusion Criteria
* past 12 month alcohol withdrawal symptoms or lifetime history of serious withdrawal symptoms (e.g., seizures)
* score above 12 on the Short alcohol withdrawal scale; SAWS
* possible drug dependence (i.e., use of illegal drugs or psychotropic medication taken without prescription more than once a month)
* indication of serious psychiatric illness (lifetime diagnosis of psychosis or bipolar disorder, inpatient treatment or medication for these, recent suicidality)
* current alcohol/drug abuse treatment or a desire to start alcohol/drug abuse treatment during the study
* medical condition that requires abstinence from alcohol
* wish to achieve abstinence (applied to secure a focus on reduction)
* lack of understanding of study protocol or reading difficulty as evidenced by a score of less than 7 out of 10 on the consent form quiz.
55 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anette Søgaard Nielsen, PhD
UNKNOWN
Kjeld Andersen, PhD
UNKNOWN
Angelina Mellentin, PhD
UNKNOWN
Alexis Kuerbis
UNKNOWN
University of Southern Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Silke Behrendt
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silke Behrendt, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Southern Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Southern Denmark, Department of Psychology
Odense, Southern Denmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID: 158341
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
SDU project nr. 3110386
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.